Comparative modeling methods: Application to the family of the mammalian serine proteases

Proteins: Structure, Function, and Bioinformatics

Volumn 7, Issue 4, 1990, Pages 317-334

  Greer, Jonathan ^a  

^a Pharmaceutical Products Division ^*  (United States)

Author keywords

computer modeling; protein structure; sequence homology; structure homology; structure prediction

Indexed keywords

BLOOD CLOTTING FACTOR; CHYMOTRYPSIN; COMPLEMENT; ELASTASE; HAPTOGLOBIN; KALLIKREIN; SERINE PROTEINASE; TRYPSIN;

AMINO ACID SEQUENCE; ARTHROPOD; ARTICLE; CATTLE; COMPUTER; COMPUTER ANALYSIS; HUMAN; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPTILE; SWINE;

ALGORITHMS; AMINO ACID SEQUENCE; ANIMAL; COMPARATIVE STUDY; COMPUTER SIMULATION; HUMAN; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, NUCLEIC ACID; SERINE ENDOPEPTIDASES;

ARTHROPODA; BOS TAURUS; MAMMALIA; REPTILIA; SUS SCROFA;

EID: 0025287330     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.340070404     Document Type: Article

References (55)

1. A possible three‐dimensional structure of bovine α‐lactalbumin based on that of hen's egg‐white lysozyme
2. Structural similarities between α‐lytic protease of Myxobacter 495 and elastase
3. Model for haptoglobin heavy chain based upon structural homology
4. Comparative model building of the mammalian serine proteases
5. On the construction of computer models of proteins by the extension of crystallographic structures
6. Protein structure and function by comparative model building
7. Three‐dimensional structure, specificity and catalytic mechanism of renin
8. The Protein Data Bank: A computer based archival file for macromolecular structures
9. A comprehensive set of sequence analysis programs for the VAX
10. Hemoglobin binding and its relationship to the serine protease‐like active site of haptoglobin
11. Identification or receptor‐binding residues in the inflammatory complement protein C5a by sitedirected mutagenesis
12. Hemoglobin‐binding site on haptoglobin probed by selective proteolysis
13. Model of a specific interaction: Salt bridges form between prothrombin and its activating enzyme blood clotting factor Xa
14. Renin inhibitors: design and synthesis of a new class of conformationally restricted analogs of angiotensinogen
15. Comparative molecular model building of two serine proteinases from cytotoxic T lymphocytes
16. Comparison of the predicted model of α‐lytic protease with the X‐ray structure
17. Critical evaluation of comparative model building of Streptomyces griseus trypsin
18. Comparison of model and nuclear magnetic resonance structures for the human inflammatory protein C5a
19. Serine proteases
20. Refined structure of α‐lytic protease at 1.7 Å resolution. Analysis of hydrogen bonding and solvent structure
21. Electron density calculations as an extensions of protein structure refinement. Streptomyces griseus protease at 1.5 Å resolution
22. Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8 Å resolution
23. Refined crystal structure of Streptomyces griseus trypsin at 1.7 Å resolution
24. Structure of crystalline α‐chymotrypsin. V. The atomic structure of tosyl‐α‐chymotrypsin at 2 Å resolution
25. The accuracy of refined protein structures: comparison of two independently refined models of bovine trypsin
26. The atomic structure of crystalline porcine pancreatic elastase at 2.5 Å resolution: Comparison with the structure of α‐chymotrypsin
27. Refined 2 Å x‐ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin‐like serine proteinase. Crystallization, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin
28. The structure of rat mast cell protease II at v1.9 Å resolution
29. Rat submaxillary gland serine proteinase, tonin: Structure solution and refinement at 1.8 Å resolution
30. The refinement and the structure of the dimer of α‐chymotrypsin at 1.67 Å resolution
31. Refined crystal structure of α‐chymotrypsin at 1.9 Å resolution: comparison with other pancreatic serine proteases
32. The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
33. Chymotrypsinogen:2.5 Å crystal structure, comparison with α‐chymotrypsin, and implications for zymogen activation
34. Bovine chymotrypsinogen A: X‐ray crystal structure and refinement of a new crystal form at 1.8 Å resolution
35. On teh disordered activation domain in trypsinogen. Chemical labelling and low temperature crystallography
36. Structure of bovine trypsinogen at 1.9 Å resolution
37. A systematic approach to the comparison of protein structures
38. The taxonomy of protein structure
39. Computer Analysis of Nucleic Acid Sequences
40. Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes
41. Prediction of the folding of short polypeptide segments by uniform conformational sampling
42. Chain closure with bond angle variations
43. Predicting antibody hypervariable loop conformational. I. Ensembles of random for ringlike structures
44. An aligorithm for determining the conformation of polypeptide segments in proteins by systematic search
45. Search Strategies for Determining the Bioactive Conformers of Peptides and Small Molecules
46. Computer simulation of the conformational properties of oligopeptides: Comparison of theoretical methods and analysis of experimental results
47. Structure, energetic, and dynamics of ligand binding to dihydrofolate reductase
48. Determination of three‐dimensional protein structures from nuclear magnetic resonance data using fragments of known structures
49. The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure
50. Predicting antibody hypervariable loop conformations. II. Minimization and molecular dynamics studies of MCPC603 from many randomly generated loop conformations
51. Mechanisms of zymogen activation
52. Complete primary structure for the zymogen of human complement factor B
53. Isolation of cDNA clones for human complement component C2
54. The Proteolytic activation systems of complement